Aditya Birla Lifestyle Brands Limited announced the full and timely repayment of Rs 200 crore to holders of commercial paper with ISIN INE14LE14103 on November 11, 2026, as per maturity, according to a filing with the BSE Limited.

Adani Enterprises Limited announced that its wholly-owned subsidiary, Adani Global Limited, incorporated a step-down wholly-owned subsidiary, Adani Rovuma Chemicals Limited, in the United Arab Emirates on November 10, 2026, with a paid-up share capital of USD 100,000.

ADHATA GLOBAL LIMITED has rescheduled its board meeting from November 12, 2026, to November 14, 2026, to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2026, according to a regulatory filing with the BSE Ltd. The company also closed its trading window for securities from October 1, 2026, until 48 hours after the financial results are declared.

Aditya Birla Money Limited will hold a board meeting on Saturday, November 14, 2026, to consider and approve a proposal for raising of funds, according to a regulatory filing with the BSE Limited and National Stock Exchange of India Limited. The trading window for designated persons and their immediate relatives has been closed and will remain so until November 16, 2026, in compliance with SEBI (Prohibition of Insider Trading) Regulations.

Aditya Birla Fashion and Retail Limited announced that Sunirmal Talukdar (DIN: 00920608) has completed his term and consequently ceased to be an Independent Director of the company effective November 10, 2026.

Aegis Logistics Limited has received approval to launch a qualified institutions placement of equity shares with a floor price of Rs 1,161.85 per share, according to a regulatory filing with the Bombay Stock Exchange and the National Stock Exchange of India on November 11, 2026; the company may offer a discount of not more than 5% on the floor price, and the issue price will be determined by the Fund Raising Committee in consultation with book running lead managers.

Algoquant Fintech Limited will hold a board meeting on Saturday, November 14, 2026, to consider and approve the unaudited standalone and consolidated financial results for the second quarter and half year ended September 30, 2026, along with a limited review report; the trading window for the company's securities will remain closed for 48 hours following the meeting's outcome.

Alivus Life Sciences Limited, formerly Glenmark Life Sciences Limited, announced that the closing under a share purchase agreement to acquire a 76% stake in IQGEN -X Pharma Private Limited has been initiated, with 7,36,096 equity shares, representing 65.01% of the issued and paid-up equity share capital of IQGEN -X, now acquired, making IQGEN -X a subsidiary of Alivus Life Sciences Limited effective November 11, 2026.

Amarnath Securities Limited has postponed and rescheduled its board meeting from November 12, 2026, to November 14, 2026, to consider the Unaudited Financial Results for the quarter and half-year ended September 30, 2026, a proposal for the issuance and allotment of up to 11,00,000 Equity Shares on a preferential basis, a plan to raise up to Rs 50,00,00,000 through equity shares and/or securities convertible into equity shares, the issuance and allotment of convertible warrants on a preferential basis, and other related matters, all subject to shareholder and regulatory approvals.

Aqylon Nexus Limited, formerly known as Sri Adhikari Brothers Television Network Limited, will hold a board meeting on November 14, 2026, to approve the unaudited financial results for the quarter ended September 30, 2026, and other business matters. The company initiated a trading window closure for insiders, designated persons, and their immediate relatives on October 1, 2026, which will remain in effect until 48 hours after the financial results are declared.